MESO logo

Mesoblast Limited (MESO)

Profile

Full Name

Mesoblast Limited

Ticker Symbol

MESO

Exchange

NASDAQ

Country

Australia

IPO

January 20, 2010

Indexes

Not included

Employees

73

Key Details

Price

$10.57

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$5.90M(-21.32% YoY)

Annual EPS

-$89.10(+15.38% YoY)

PE Ratio

-

Next earnings date

Apr 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Feb 7, 25 Piper Sandler
Overweight
Dec 23, 24 Jefferies
Hold
Dec 19, 24 Piper Sandler
Overweight
Jul 23, 24 Piper Sandler
Overweight
Jun 20, 24 Cantor Fitzgerald
Overweight
Jun 4, 24 Cantor Fitzgerald
Overweight
Sep 21, 23 Cantor Fitzgerald
Overweight
Aug 31, 23 Jefferies
Buy
Aug 31, 23 Cantor Fitzgerald
Overweight
Aug 7, 23 Maxim Group
Hold

Institutional Ownership

  • What is the ticker symbol for Mesoblast Limited?
  • Does Mesoblast Limited pay dividends?
  • What sector is Mesoblast Limited in?
  • What industry is Mesoblast Limited in?
  • What country is Mesoblast Limited based in?
  • When did Mesoblast Limited go public?
  • Is Mesoblast Limited in the S&P 500?
  • Is Mesoblast Limited in the NASDAQ 100?
  • Is Mesoblast Limited in the Dow Jones?
  • When was Mesoblast Limited's last earnings report?
  • When does Mesoblast Limited report earnings?
  • Should I buy Mesoblast Limited stock now?

What is the ticker symbol for Mesoblast Limited?

The ticker symbol for Mesoblast Limited is NASDAQ:MESO

Does Mesoblast Limited pay dividends?

No, Mesoblast Limited does not pay dividends

What sector is Mesoblast Limited in?

Mesoblast Limited is in the Healthcare sector

What industry is Mesoblast Limited in?

Mesoblast Limited is in the Biotechnology industry

What country is Mesoblast Limited based in?

Mesoblast Limited is headquartered in Australia

When did Mesoblast Limited go public?

Mesoblast Limited's initial public offering (IPO) was on January 20, 2010

Is Mesoblast Limited in the S&P 500?

No, Mesoblast Limited is not included in the S&P 500 index

Is Mesoblast Limited in the NASDAQ 100?

No, Mesoblast Limited is not included in the NASDAQ 100 index

Is Mesoblast Limited in the Dow Jones?

No, Mesoblast Limited is not included in the Dow Jones index

When was Mesoblast Limited's last earnings report?

Mesoblast Limited's most recent earnings report was on Feb 26, 2025

When does Mesoblast Limited report earnings?

The next expected earnings date for Mesoblast Limited is Apr 30, 2025

Should I buy Mesoblast Limited stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page